Metraipolis › archive › dc_8a66abc4588c

Current and emerging drugs for Parkinson's disease: mechanisms, clinical evidence, and future directions — Europe PMC PMID:42445254

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42445254
DOI
10.3389/fphar.2026.1805370
License (as archived)
solo-consultazione
Archived
2026-10-31T07:24:55.737Z
SHA-256 of the archived text
70ba573de7fe0edca1069107a69658635e714fe7a7de25d490cad32bad4fae46
Stable URL of this page
https://metraipolis.com/documento/dc_8a66abc4588c

How to cite

Current and emerging drugs for Parkinson's disease: mechanisms, clinical evidence, and future directions — Europe PMC PMID:42445254 — Europe PMC (en), https://europepmc.org/article/MED/42445254 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8a66abc4588c (Metraipolis archive dc_8a66abc4588c, sha256 70ba573de7fe0edca1069107a69658635e714fe7a7de25d490cad32bad4fae46)
BibTeX
@misc{dc8a66abc4588c,
  title = {Current and emerging drugs for Parkinson's disease: mechanisms, clinical evidence, and future directions — Europe PMC PMID:42445254},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42445254},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8a66abc4588c; sha256 70ba573de7fe0edca1069107a69658635e714fe7a7de25d490cad32bad4fae46},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42445254. Agents can read the archived copy with the MCP tool read_document.